UNSPSC 51162743: Terpin hydrate

This classification denotes a menthol analog, insect repellent, and expectorant with the molecular formula C10H20O2.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S3V868548T, chemically known as 1,8-terpin but more generally known as terpin hydrate, which bears US NIH Compound Identifier 6651. European Medicines Agency schedules Terpin hydrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15488MIG. As of Q4 2014, TERPIN HYDRATE remains US FDA's Preferred Term for this commodity.

SMILES: CC1(CCC(CC1)C(C)(C)O)O.O.

UNSPSC 51162743 Terpin hydrate is a Commodity code under which state and local governments procure pharmaceutical and medical products for healthcare delivery and public health interventions. Recent solicitations under this code show state and local agencies buying parenteral nutrition solutions, intravenous products, naloxone, and related medical equipment to support correctional health systems and community health initiatives. The Washington State Department of Corrections and Seminole County, Florida have posted opportunities in the past four months, indicating that departments of corrections, county health agencies, and local public health programs are the primary issuing bodies. Work under the code involves supplying finished pharmaceutical products with strict delivery timelines and cold-chain or temperature-control requirements, as well as furnishing medical equipment such as drug deactivation systems. Contractors must demonstrate pharmaceutical licensing, appropriate insurance coverage (including professional liability and cyber liability), and ability to meet rapid delivery windows — the Washington DOC opportunity requires parenteral nutrition bags within 24 hours of order and other parenteral products within 8 hours.

The code shows recent activity concentrated in the Pacific Northwest and Southeast. The Washington State Department of Corrections issued RFQ RFQQK13020 on September 8, 2026, with a response deadline of October 7, 2026, seeking parenteral products and services across eight facilities in three regions (West, Central, and East), with contract start November 26, 2026 through June 30, 2030 and potential award to up to three bidders per region; the solicitation encourages participation from small businesses, minority-owned businesses, women-owned businesses, and veteran-owned businesses under Washington's chapter 39.19 RCW. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, requesting 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, on a two-year initial contract with one-year renewal option. Both opportunities indicate steady government procurement of pharmaceutical inventory and medical supplies to meet statutory healthcare obligations in correctional and community health settings.